NCT06372678View on ClinicalTrials.gov

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic Rhinosinusitis With Nasal Polyps
Interventions
BIOLOGICAL

CM326

CM326 injection

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Beijing Tongren Hospital, CMU, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06372678 - Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis | Biotech Hunter | Biotech Hunter